Fedratinib – November 2025

• Brand names:
  • Inrebic®
• Pharmaceutical Company:
  • BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD
• Condition/Indication: Myelofibrosis
• Meeting Date: November 2025
• Public Summary Document (PSD) November 2025 PBAC Meeting - (PDF 941.9KB)
• Public Summary Document (PSD) November 2025 PBAC Meeting - (Word 207.8KB)